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Abstract
DNA methylation by de novo DNA methyltransferases 3A (DNMT3A) and 3B (DNMT3B) is 
essential for genome regulation and development1, 2. Dysregulation of this process is implicated in 
various diseases, notably cancer. However, the mechanisms underlying DNMT3 substrate 
recognition and enzymatic specificity remain elusive. Here we report a 2.65-Å crystal structure of 
the DNMT3A-DNMT3L-DNA complex where two DNMT3A monomers simultaneously attack 
two CpG dinucleotides, with the target sites separated by fourteen base pairs within the same DNA 
duplex. The DNMT3A–DNA interaction involves a target recognition domain (TRD), a catalytic 
loop and DNMT3A homodimeric interface. A TRD residue Arg836 makes crucial contacts with 
CpG, ensuring DNMT3A enzymatic preference towards CpG sites in cells. Hematological cancer-
associated somatic mutations of the substrate-binding residues decrease DNMT3A activity, induce 
CpG hypomethylation, and promote transformation of hematopoietic cells. Together, our study 
reveals the mechanistic basis for DNMT3A-mediated DNA methylation and establishes its 
etiologic link to human disease.
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Mammalian DNA methylation is an important epigenetic mechanism crucial for gene 
silencing and imprinting, X-inactivation, genome stability, and cell fate determination3. It is 
established mainly at CpG dinucleotides by de novo methyltransferases DNMT3A and 
DNMT3B1, 2, and subsequently maintained by DNA methyltransferase 1 (DNMT1) in a 
replication-dependent manner4. The enzymatic function of DNMT3A and DNMT3B is 
further regulated by DNMT3-like protein (DNMT3L) in germ and embryonic stem cells 
(ESCs)5–7. Deregulation of DNMT3A and DNMT3B is associated with various human 
diseases including hematological cancer8–10. However, the molecular mechanisms 
underpinning DNMT3A-mediated methylation, especially substrate recognition and 
catalytic preference towards CpG, remain elusive. Here we generated a productive 
DNMT3A–DNMT3L–DNA complex using the C-terminal domains of DNMT3A and 
DNMT3L (Fig. 1a). The DNA molecule consists of a 10-mer, central CpG-containing DNA 
strand annealed to an 11-mer, 2′-deoxy-Zebularine (dZ)-containing strand (target strand), 
which results in a (CpG) • (dZpG) sequence context and permits formation of stable, 
covalent DNMT3A–DNA complexes (Extended Data Fig. 1a,b). The crystal structure of the 
DNMT3A–DNMT3L–10/11-mer DNA complex, bound to cofactor byproduct S-Adenosyl-
L-homocysteine (AdoHcy), was subsequently determined at 3.1 Å resolution (Extended 
Data Fig. 1c).
The structure of this DNMT3A–DNMT3L–DNA complex reveals a tetrameric fold arranged 
in the order of DNMT3L–DNMT3A–DNMT3A–DNMT3L, reminiscent of its DNA-free 
form11, 12 (Extended Data Fig. 1d, 2a). Notably, two DNA duplexes, each bound to one 
DNMT3A monomer, are separated by ~15 Å, implying a total of 14-base pair (bp) spacing 
between the two active sites of DNMT3A (Extended Data Fig. 1d). This finding prompted 
us to design a longer DNA substrate involving a self-complementary 25-mer Zebularine (Z)-
containing DNA, with two (CpG) • (ZpG) sites across 14 bp (Fig. 1b). The structure of the 
DNMT3A–DNMT3L–25-mer DNA complex was determined at 2.65 Å resolution 
(Extended Data Fig. 1c), revealing only one DNA duplex bending towards the DNMT3A-
DNMT3L tetramer, with the two CpG sites simultaneously anchored by two DNMT3A 
monomers (Fig. 1c,d and Extended Data Fig. 2b). Our data thus support a notion that the 
two DNMT3A monomers can co-methylate two adjacent CpG dinucleotides in one DNA-
binding event12, 13. Despite being crystalized under different conditions, both DNMT3A–
DNMT3L–DNA complexes are well aligned with their DNA-free state, with a root-mean-
square deviation of 0.87 Å and 1.12 Å over 790 and 826 Cα atoms, respectively (Extended 
Data Fig. 2a). Notably, in DNMT3A–DNMT3L–DNA complexes, Zebularines are flipped 
out of the DNA helix and inserted deep into DNMT3A catalytic pockets, where they are 
covalently anchored by the catalytic cysteine C710 and hydrogen bonded to E756, R790 and 
R792 (Fig. 1c and Extended Data Fig. 1d). Since both structures reveal productive reaction 
states with consistent protein–DNA interactions, we focus on the structure of DNMT3A–
DNMT3L–25-mer DNA for further analysis.
DNMT3A binding to DNA is mainly mediated by a loop from the target recognition domain 
(TRD) (residues R831-F848), the catalytic loop (residues G707-K721) and the homodimeric 
interface of DNMT3A, which together create a continuous DNA-binding surface (Fig. 1d, 
2a). Accordingly, these segments exhibit the most prominent structural changes upon DNA 
binding – the TRD loop lacked electron density in the DNA-free structure of DNMT3A–
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DNMT3L11, 12, but became well defined upon DNA binding and penetrated into the DNA 
major groove for intermolecular contacts (Fig. 2a–c); additionally, the TRD loop is 
stabilized through hydrogen-bonding interactions with R882, the DNMT3A mutational 
hotspot among leukemias9, 10, and Q886 from an adjacent helix (Fig. 2c). Meanwhile, the 
catalytic loop residue V716 moves towards the DNA minor groove by ~2 Å, intercalating 
into the DNA cavity vacated due to Zebularine base flipping (Fig. 2d,e). Although no 
protein-DNA contact was observed for DNMT3L, two DNMT3L-contacting helices of 
DNMT3A are preceded by DNA-binding loops (Extended Data Fig. 2c), reinforcing a 
notion that DNMT3L enhances DNMT3A functionality through stabilizing its DNA-binding 
sites12.
Recognition of CpG dinucleotides by DNMT3A is mediated by both catalytic and TRD 
loops. In particular, guanine of the target strand, G6 (G19′), is specified by a hydrogen bond 
between its O6 atom and the Nε atom of R836 from the TRD loop, as well as water-
mediated hydrogen bonds between its N7 atom and the Nε and Oγ atoms of R836 and 
T834, respectively (Fig. 3a). Meanwhile, the catalytic loop approaches to the minor groove 
where the backbone carbonyl oxygen of V716 forms a hydrogen bond with the N2 atom of 
the unpaired guanine G5′ (G20) (Fig. 3b). Penetration of the catalytic loop also permits 
V716 and P718 to engage van de Waals contacts with the base of G6 (G19′), providing 
additional base-specific recognition (Fig. 3b). No protein interaction was associated with 
C6′ (C19) of the non-target strand, lending explanation for the observation that DNMT3A 
does not discriminate hemimethylated over unmethylated DNA2. Formation of the 
DNMT3A–DNA complex is also supported by various protein–DNA interactions flanking 
CpG, which involve electrostatic and/or hydrogen-bonding interactions of the TRD residues 
(R831, T832, T835, N838 and K841), catalytic loop residues (N711, S714 and I715) and 
DNMT3A–DNMT3A homodimeric interface residues (S881, R882, L883 and R887) with 
various DNA backbone or base sites (Fig. 2a and Extended Data Fig. 3a–f). These DNA-
binding residues are highly conserved in DNMT3B (Extended Data Fig. 3g), suggesting a 
similar substrate engagement mechanism used by the DNMT3 family.
To determine the roles for CpG-engaging residues R836 and V716 in regulation of 
DNMT3A activity, we performed mutagenesis followed by enzymatic studies using CpG-, 
CpA- or CpT-containing substrates (Fig. 3c and Extended Data Fig. 4a–b). First, wild-type 
(WT) DNMT3A showed methylation efficiency for CpG-containing DNA >20-fold higher 
than for CpA- or CpT-containing DNA, confirming its well-known CpG specificity14. In 
contrast, mutation of R836 to alanine (R836A) enhanced methylation of CpA- and CpT-
containing DNA by 5.2- and 4.2-fold, respectively, but, as previously reported15, only led to 
slight change in CpG methylation. As a result, the relative CpG/CpA and CpG/CpT 
preference of the DNMT3AR836A enzyme was reduced by 4.5- and 3.7-fold, respectively, 
supporting a role for R836 in substrate specificity determination. In line with these 
observations, we solved the structure of DNMT3AR836A–DNMT3L–DNA complex, which 
lacks R836-mediated hydrogen bonds to CpG without causing overall structural alterations 
(Extended Data Fig. 4c). Meanwhile, mutation of V716 to glycine (V716G) abolished 
methylation of all tested substrates (Extended Data Fig. 4d). These observations support that 
R836-mediated CpG engagement contributes to substrate specificity whereas V716-
mediated intercalation is essential for DNMT3A-mediated catalysis. The increased in vitro 
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activity of DNMT3AR836A on CpA and CpT suggests that R836 might energetically 
influence enzymology of DNMT3A, in addition to target recognition. In the case of CpG 
DNA, such influence might be partly compensated by the R836-mediated hydrogen bond, 
thereby ensuring the CpG specificity of DNMT3A.
Next, we introduced comparable levels of DNMT3A, either WT or the above CpG-
engagement-defective mutants, into ESCs with compound knockouts of DNMT1, DNMT3A 
and DNMT3B (TKO)16, and detected global increase in cytosine methylation after rescue 
with DNMT3AWT or DNMT3AR836A, but not DNMT3AV716G (Extended Data Fig. 4e,f). 
Furthermore, genome-wide methylation profiling with enhanced reduced representation 
bisulfite sequencing (eRRBS), followed by calling of methylation using the previously 
described binomial model and false discovery rate (FDR)-based threshold17, 18, revealed 
that, in TKO ESCs reconstituted with DNMT3AWT, 58% and 42% of methylated cytosines 
were presented at CpG and non-CpG sites, respectively (Fig. 3d and Extended Data Fig. 5a–
c); in contrast, such distribution was reversed in cells expressing DNMT3AR836A, with 31% 
and 69% of methylated cytosines found at CpG and non-CpG contexts (Fig. 3d and 
Extended Data Fig. 5b,c). Consistently, relative to WT controls, the absolute methylation 
levels were found decreased at CpG but increased at CpA and CpC sites among cells with 
DNMT3AR836A, especially at sites showing intermediate to high levels of methylation (Fig. 
3e and Extended Data Fig. 5d,6a). These changes were persistent among all chromosomes, 
at both DNA strands and over all annotated genes (Extended Data Fig. 6b–d), as exemplified 
by those detected at the major satellite DNA repeats (Fig. 3f) and gene-coding regions of 
Foxp1 and Dock1 (Extended Data Fig. 6e). Sanger bisulfite sequencing further validated 
eRRBS results at major satellite repeats in ESCs (Fig. 3g and Extended Data Fig. 7)19. 
Meanwhile, DNMT3AV716G abolished both CpG and non-CpG methylations at major 
satellite DNA (Extended Data Fig. 7b–d). The above observation that DNMT3AR836A 
decreases overall CpG methylations in TKO cells might be due to competition of non-CpG 
as potential substrate for this mutant enzyme. Collectively, we demonstrate that engaging 
CpG by the R836 side chain ensures DNMT3A substrate specificity.
Notably, heterozygous mutation of DNMT3A at its DNA-binding residues, such as S714, 
V716, P718, R792, T835, R836, N838, K841 and R882 (Fig. 2a and 4a,b), occurs 
recurrently in hematological cancer9, 10, 20 and overgrowth syndrome21. While recent studies 
support a dominant-negative effect of the hotspot R882H mutation on DNMT3A-mediated 
methylation possibly through affecting DNMT3A tetramerization22–25, our structural 
observation raises a possibility that interfering with the DNA binding via residue 
substitution also results in functional impairment of DNMT3A during pathogenesis. Indeed, 
in vitro enzymatic assays showed the significantly reduced activity for all tested DNA-
binding mutants, with most pronounced effect observed for V716D, R792H and K841E 
(Fig. 4c and Extended Data Fig. 8a–d). Consistently, expression of these three mutants in 
TKO ESCs failed to restore global DNA methylation (Extended Data Fig. 8e–f). It is worth 
noting that, while DNMT3AR836W exhibited modestly reduced overall activities (Extended 
Data Fig. 8c, f), its activities for non-CpG methylations were found significantly increased at 
the major satellite DNA in TKO cells and in in vitro enzymatic assays (Extended Data Fig. 
8g,h), suggesting a potential role of R836W in redistribution of CpG versus non-CpG 
methylations in diseased cells. Given a largely heterozygous feature of DNMT3A mutations 
Zhang et al. Page 4
Nature. Author manuscript; available in PMC 2018 August 07.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
in leukemia, we also queried whether the DNA-binding-defective mutants of DNMT3A 
inhibit functionality of DNMT3AWT. To test this, we turned to a co-expression system used 
previously for studying the domain-negative DNMT3AR882H mutant23, and reconstituted 
WT and mutant DNMT3A in equal amounts into TKO ESCs (Fig. 4d). Relative to 
expression of WT alone, co-expression of DNMT3AV716D, DNMT3AR792H or 
DNMT3AK841E with DNMT3AWT significantly decreased overall cytosine methylation 
(Fig. 4d). Together, we show that the DNMT3A mutants defective in substrate binding not 
only have decreased activity but also interfere with that of DNMT3AWT.
We further ectopically expressed the above DNMT3A mutants in TF-1 cells, a model used 
for studying leukemia-associated gene mutation26. Through array profiling and bisulfite 
sequencing validation, we observed significant reduction of overall CpG methylations in 
TF1 cells stably expressing either DNMT3AV716D, DNMT3AR792H or DNMT3AK841E, 
relative to control; in contrast, ectopic expression of DNMT3AWT induced hyper-
methylation (Fig. 4e and Extended Data Fig. 9). There is significant overlap among CpG 
sites showing hypo-methylation due to expression of DNMT3AV716D, DNMT3AR792H or 
DNMT3AK841E (Extended Data Fig. 10a), indicating their common effect on epigenomic 
deregulation. Reduced methylation of these commonly affected sites was also detected post-
transduction of other leukemia-associated substrate-binding mutations of DNMT3A (P718L, 
T835M, R836W and N838D), although the latter did not induce hypo-methylation globally 
(Extended Data Fig 10b–c). Binding of WT or mutant DNMT3A was comparable at tested 
loci showing methylation changes (Extended Data Fig 10d–e). Given that epigenetic 
deregulation promotes TF-1 cell transformation characterized by cytokine-independent 
growth26, we queried whether the DNA-binding-defective mutation of DNMT3A causes 
similar transformation of this model. We found that, under cytokine-supporting conditions, 
TF-1 cells expressing WT or mutant DNMT3A exhibited comparable proliferation 
(Extended Data Fig. 10f). In contrast, those expressing a DNA-binding-defective mutant, but 
not DNMT3AWT, had significant cytokine-independent growth capability (Fig. 4f and 
Extended Data Fig. 10g). Collectively, we demonstrate that the DNA-binding residues of 
DNMT3A are vital for establishment of appropriate CpG methylation in hematological cells 
and that their somatic mutations detected in leukemia patients promote transformation.
Methods
Protein expression and purification
The gene fragments encoding residues 628-912 of human DNMT3A (NCBI accession 
NM_022552) and residues 178-386 of human DNMT3L were inserted in tandem into a 
modified pRSFDuet-1 vector (Novagen). The DNMT3A sequence was separated from the 
preceding His6-SUMO tag by a ubiquitin-like protease (ULP1) cleavage site. Expression and 
purification of the DNMT3A–DNMT3L complex followed a previously described 
protocol27. In short, the His6-SUMO-DNMT3A fusion protein and DNMT3L was co-
expressed in E. coli BL21 DE3 (RIL) cell strains and purified using a Ni2+-NTA column. 
Subsequently, the His6-SUMO tag was removed through ULP1-mediated cleavage, followed 
by ion exchange chromatography on a Heparin column. For enzymatic assay, the 
DNMT3A–DNMT3L complex was further purified through size exclusion chromatography 
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on a Superdex 200 16/60 column (GE Healthcare), and concentrated to 0.1-0.3 mM in a 
buffer containing 20 mM Tris-HCl (pH 8.0), 100 mM NaCl, 0.1% β-mercaptoethanol and 
5% glycerol. To generate the covalent DNMT3A–DNMT3L–DNA complex, a 11-mer 
single-stranded DNA that was in-house synthesized to contain 2′-deoxy-Zebularine28 (5′- 
CATGdZGCTCTC -3′, dZ = 2′-deoxy-Zebularine) was annealed with a 10-mer single-
stranded DNA (5′- AGAGCGCATG -3′) before reaction with the DNMT3A–DNMT3L 
complex in the presence of 20 mM Tris-HCl (pH 7.5), 50 mM NaCl, 20% Glycerol and 40 
mM DTT at room temperature. In addition, a 25-mer Zebularine-containing DNA (5′- 
GCATGZGTTCTAATTAGAACGCATG -3′, Z = Zebularine) was self-annealed and used to 
form a second DNMT3A–DNMT3L–DNA complex or the DNMT3A (R836A)–DNMT3L–
DNA complex. The reaction products were further purified through a HiTrap Q XL column 
(GE Healthcare), followed by size exclusion chromatography on a Superdex 200 16/60 
column. The final samples for crystallization of the productive DNMT3A–DNMT3L–DNA 
complexes contain about 0.1-0.2 mM covalent DNMT3A–DNMT3L–DNA complexes, 0.3 
mM AdoHCy, 20 mM Tris-HCl (pH 8.0), 100 mM NaCl, 0.1% β-mercaptoethanol and 5% 
glycerol.
Crystallization conditions and structure determination
The crystals for the covalent complex of DNMT3A–DNMT3L with the 10/11-mer DNA 
were generated by hanging-drop vapor-diffusion method at 23 °C, from drops mixed from 
0.5 μl of DNMT3A–DNMT3L–DNA solution and 0.5 μl of precipitant solution [7% 
PEG4000, 0.1 M Tris-HCl (pH 8.5), 100 mM MgCl2, 166 mM imidazole (pH 7.0)]. The 
reproducibility and quality of crystals were further improved by the micro-seeding method. 
The crystals were soaked in cryoprotectant made of mother liquor supplemented with 30% 
PEG400, before flash frozen in liquid nitrogen. For the complex of DNMT3A (either wild-
type or R836A mutant) with DNMT3L and the 25-mer DNA, crystals were generated by 
hanging-drop vapor diffusion method at 4 °C, from drops mixed from 1.5 μl of the protein 
solution and 1.5 μl of precipitation solution [0.1 M Tris-HCl (pH 7.0), 200 mM NaH2PO4 
and 5% PEG4000]. The crystals were treated with cryoprotectant containing the 
precipitation solution and 30% glycerol before harvesting.
X-ray diffraction data sets for the covalent DNMT3A–DNMT3L–DNA complexes were 
collected at selenium peak wavelength on the BL501 or BL502 beamlines at the Advanced 
Light Source (ALS), Lawrence Berkeley National Laboratory, and the data set for the 
covalent DNMT3A (R836A)–DNMT3L–DNA complex was collected on the 24-ID-E NE-
CAT beamline at the Advanced Photon Source (APS), Argonne National Laboratory. The 
diffraction data were indexed, integrated and scaled using the HKL 2000 program29 or the 
XDS program30. The structures of the productive covalent complexes of DNMT3A–
DNMT3L–DNA were solved using the molecular replacement method in PHASER31, with 
the DNA-free structure of DNMT3A–DNMT3L (PDB 2QRV) serving as a search model. 
Further modeling of the covalent DNMT3A–DNMT3L–DNA complexes was carried out 
using COOT32 and then subject to refinement using the PHENIX software package33. The 
same R-free test set was used throughout the refinement. The final models for DNMT3A–
DNMT3L complexed with the 25-mer and 10/11-mer DNAs were refined to 2.65 Å and 3.1 
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Å resolution, respectively. The final model for DNMT3A (R836A)–DNMT3L complexed 
with the 25-mer DNA was refined to 3.0 Å resolution.
The statistics for data collection and structural refinement of the productive covalent 
DNMT3A–DNMT3L–DNA complexes is summarized in Extended Data Fig. 1c.
In vitro DNA methylation assay
Synthesized (GAC)12, (AAC)12 and (TAC)12 DNA duplexes were used as CG-, CA- and CT-
containing substrates, respectively. The DNA methylation assays were carried out in 
triplicate at 37 °C for 1 hr., unless otherwise indicated. Briefly, a 20-μL reaction mixture 
contained 2.5 μM S-adenosyl-L-[methyl-3H]methionine (AdoMet) (specific activity 18 Ci/
mmol, PerkinElmer), 0.3 μM DNMT3A-DNMT3L, 0.75 μM DNA in 59 mM Tris-HCl, pH 
8.0, 0.05% β-mercaptoethanol, 5% glycerol and 200 μg/mL BSA. The methylation reactions 
were stopped by flash freezing in liquid nitrogen, followed by precipitation and incubation 
on ice for 1 hr. in 1 ml of 15% trichloroacetic acid (TCA) solution plus 40 μg/ml BSA. The 
TCA-precipitated samples were then passed through a GF/C filter (GE Healthcare) using a 
vacuum-filtration apparatus. After sequential washing with 2 × 5 ml of cold 10% TCA and 5 
ml of ethanol, the filters were dried and transferred to scintillation vials filled with 5 ml of 
ScintiVerse (Fisher), followed by measurement of tritium scintillation with a Beckman 
LS6500 counter.
Plasmid construction
Full-length human DNMT3A isoform 1 was cloned into EcoRI site of the pPyCAGIZ vector 
(a kind gift of Dr. Jianlong Wang, Ican School of Medicine at Mount Sinai). DNMT3A 
mutation was generated by QuikChange II XL Site-Directed Mutagenesis Kit (Agilent). To 
achieve co-expression of the wildtype (WT) and mutant DNMT3A at equal levels in cells, 
we engineered a T2A-based fusion construct consisting of the mutant cDNA, which was 
added with an N-terminal 3×Flag-(GGGGS)3-Myc tag to differentiate its protein size from 
non-tagged WT DNMT3A, followed by a T2A peptide sequence at its C-terminus and the 
cDNA of non-tagged WT DNMT3A. Myc-tagged full-length human DNMT3A isoform 1 
were cloned into MSCV Pac retroviral vector as previously described24. All plasmid 
sequences were verified by sequencing.
Cell lines and cell culture
Dnmt3a, Dnmt3b and Dnmt1 triple knockout (TKO) mouse ES cells (a kind gift from Dr. 
Masaki Okano, RIKEN Center for Developmental Biology)16 were cultivated on gelatin-
coated dishes in the high-glucose DMEM base medium (Invitrogen) supplemented with 15% 
of fetal bovine serum (FBS, Invitrogen), 1 × nonessential amino acids (Invitrogen), 0.1 mM 
β-mercaptoethanol, and 1000 U/ml leukemia inhibitory factor (ESGRO). The TF-1 human 
erythroleukemic cell line was obtained from ATCC and cultivated in the RPMI 1640 base 
medium (Invitrogen) supplemented with 10% of FBS and 2 ng/ml of recombinant human 
GM-CSF (R&D Systems). Acquisition of the cytokine-independent growth of TF1 cells due 
to introduction of cancer-associated gene mutation was examined and quantified upon GM-
CSF removal as previously described26.
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Authentication of cell line identities, including those of parental and derived lines, was 
ensured by the Tissue Culture Facility (TCF) affiliated to UNC-Chapel Hill Lineberger 
Comprehensive Cancer Center using the genetic signature profiling and fingerprinting 
analysis as previously described34. Every 1-2 month, a routine examination of cell lines in 
culture for any possible mycoplasma contamination was carried out using the commercially 
available detection kits (Lonza Walkersville Inc).
Generation of stable cell lines
TKO ES cells were transfected by Lipofectamine 2000 (Invitrogen) with the pPyCAGIZ 
empty vector (EV) or that carrying WT or mutant DNMT3A. 48 hours post transfection, the 
transduced ES cells were selected out in 50 μg/ml Zeocin (Invitrogen) for 10 days. The 
pooled stable-expression cell lines and independent single cell-derived clonal lines were 
continuously maintained in the medium with 25 μg/ml Zeocin. To generate TF-1 leukemia 
cell lines with stable expression of WT or mutant DNMT3A, the MSCV-based retrovirus 
was packaged in HEK293 and used for infection as previously described35. 48 hrs post 
infection, TF-1 cells were selected by 2 μg/ml puromycin for 4 days and maintained in 
medium with 1μg/ml puromycin.
Western blotting
Antibodies used for western blotting were α-MYC (Sigma, 9E10), α-DNMT3A (Santa 
Cruz, H-295), α-beta-Actin (Santa Cruz, sc-47778), and α-Tubulin (Sigma). Total protein 
samples were prepared by cell lysis with SDS-containing Laemmli sample buffer followed 
by brief sonication. Extracted samples equivalent to 100,000 cells were loaded to the SDS-
PAGE gels for western blot analysis.
Quantification of 5-methyl-2´-deoxycytidine (5-mdC) and 2´-deoxyguanosine (dG) in 
genomic DNA
The measurement procedures for 5-mdC and dG in genomic DNA were described 
previously36, 37. Briefly, 1 μg of genomic DNA prepared from cells was enzymatically 
digested into nucleoside mixtures. Enzymes in the digestion mixture were removed by 
chloroform extraction, and the resulting aqueous layer was concentrated to 10 μL and 
subjected directly to LC-MS/MS and LC-MS/MS/MS analysis for quantification of 5-mdC 
and dG, respectively. The amounts of 5-mdC and dG (in moles) in the nucleoside mixtures 
were calculated from area ratios of peaks found in selected-ion chromatograms (SICs) for 
the analytes over their corresponding isotope-labeled standards, the amounts of the labeled 
standards added (in moles) and the calibration curves. The final levels of 5-mdC, in terms of 
percentages of dG, were calculated by comparing the moles of 5-mdC relative to those of 
dG.
Enhanced Reduced Representation Bisulfite Sequencing (eRRBS) and data analysis
Genomic DNA of each sample was added with 0.5% of unmethylated lambda DNA 
(Promega) as spike-in control and subjected to eRRBS using MethylMidi-seq (Zymo 
Research) as described before24. In brief, approximately 300 ng of DNA were digested with 
three restriction enzymes (80 units of MspI, 40 units of BfaI and 40 units of MseI) to 
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improve genomic DNA fragmentation and coverage. The generated DNA fragments were 
ligated to the pre-annealed 5′-methyl-cytosine-containing adapters, followed by filling in 
overhangs and the A extension at 3′-terminus. The DNA fragments were then purified and 
subject to bisulfite treatment using the EZ DNA Methylation–Lightning kit (Zymo 
Research). After amplification, the quality of eRRBS libraries was checked with Agilent 
2200 TapeStation, followed by deep sequencing using the Illumina HiSeq-2000 genome 
analyzer (50-bp and paired end as parameters). Obtained reads were aligned to in silico 
bisulfite-converted mouse reference genome mm9 and lambda DNA sequence (GenBank: 
J02459.1) using Bismark package in a strand-specific manner38. For identification of 
methylated cytosines, all mapped cytosines were subjected to a binomial distribution model-
based methylation calling as described in the below section. To determine distribution of 
methylation levels, only those high-quality reads with at least 15 times of coverage were 
used. For convenience of data analysis and to increase data complexity, data from all three 
biological replicates were merged and cytosine sites covered with at least 15 reads in the 
merged dataset were used for downstream analysis such as analysis of averaged methylation 
levels in 10-kb window sliding and aggregated methylation levels across genes. Data 
representation and plots were generated with the ggplot2 package in R software using 
custom scripts.
Identification of methylated cytosines
We used a previously described binomial model to identify methylated cytosines17, 18. 
Specifically, with the unmethylated spike-in lambda DNA, we first determined the bisulfite 
non-conversion rate (probability, P) for each cytosine sequence context independently (i.e., 
CpG, CpA, CpC and CpT). For each mapped cytosine in our eRRBS data, we calculated the 
binomial p-value that methylated reads occur out of the total read number based on the 
binomial test, with bisulfite non-conversion rate as the success probability (P). If a p-value is 
under a threshold, we defined the cytosine as truly methylated. To determine the false 
discovery rate (FDR) for each different threshold, we created a control methylome for each 
eRRBS sample. In the control methylome, read depth at each cytosine was equal to the real 
data, and the methylated events were simulated by binomial distribution using previously 
defined non-conversion rate (P). The FDR was determined by the ratio between the number 
of identified methylated cytosine sites from the control methylome and that from the real 
data. For each eRRBS sample, we have chosen to use a p-value under which the FDR is less 
than 1% or 0.1%, as specified in figure legends.
DNA methylation array and data analysis
Genomic DNA was extracted and bisulfite-converted as described above. DNA methylation 
profiling using the lllumina Infinium HumanMethylation450 BeadChip array was performed 
by the UNC Genomics Core according to the manufacturer’s instructions. Methylation data 
were then subject to background subtraction and control normalization by executing 
preprocessIllumina in the R ‘minfi’ package39. Differentially methylated CpGs were 
identified using dmpFinder in a categorical mode. Methylation changes were considered 
significant at a q-value of less than 0.05 and a beta value difference of more than 0.1. 
Hierarchical clustering analysis, scatter plots and density plots were generated in R using 
‘pheatmap’, and ‘ggplot2’ packages.
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Sanger bisulfite sequencing
Sanger bisulfite sequencing was carried out as previously described24. Briefly, genomic 
DNA was prepared using the DNeasy Blood & Tissue Kit (Qiagen) and 1 μg genomic DNA 
subject to bisulfite conversion using the EZ DNA methylation gold kit according to 
manufacturer’s instructions (Zymo Research). Bisulfite-treated DNA was then used as 
template in PCR to amplify the target DNA region, followed by cloning of PCR products 
into pCR2.1-TOPO vector (Invitrogen) for direct sequencing of individual clones. Four 
biological replicates per cell line were tested, with at least 10 clonal sequences per replicate 
generated. The primers used for amplifying a major satellite DNA sequence located at 
chromosome 2 are 5′- GGG AAT TTT GGT GGT AGG GT -3′ and 5′- AAA AAA CAT 
CCA CTT AAC TAC TTA AAA A -3′. The primers used for validating 450k array data are 
listed as follows: for EIF4G1, 5′- AGG AGA TTG AGG TTT TAG TGA ATA TGT-3′ and 
5′- CCC TAT ATC AAA TTC TTC CTA CCA TAA -3′; for HDLBP, 5′- GGA GGT GAA 
GTT ATG GAG ATA TTT TT -3′ and 5′- ATC CCA TAC CAA CAA AAA CTA ACA 
A-3′; for FOXK2, 5′- TAT GTT TGT ATT TGG GGT GTT TTT T -3′ and 5′- CTA AAA 
AAT CAA AAA CAT TTC CTA CC -3′.
Chromatin immunoprecipitation (ChIP)
Chromatin samples used for ChIP were prepared as previously described8. Briefly, 
chromatin samples extracted from cells expressing Myc-tagged DNMT3A were used for 
ChIP with the 9E10 anti-Myc antibody (Sigma), with cells expressing empty vector used as 
negative control. Real-time PCR was carried out for detecting DNMT3A binding at sites 
listed below. The primers for ChIP-PCR at each tested site are: for cg23189692, 5′- TTG 
GCA TGC TCA CAG AGA GG -3′ and 5′- GTC TTC CCA GGC TCA TTG CT -3′; for 
cg00704780. 5′- AGC AAA ACG GTC AGT AGC CA -3′ and 5′- TAC CAG CAA AAG 
CTG GCA GG -3′; for cg10460657, 5′- GCC TCT GAC CTG CTG TCT AC -3′ and 5′- 
AGG AAA TGC CCC AGA CGT G -3′; for cg07564962, 5′- GGC CGG CAC TAA TGT 
CTT TC -3′ and 5′- TTC CCT GCT CTG TGG GAA GG -3′; for cg13393476, 5′- CCT 
TGC GAG TGA GTC ACG G -3′ and 5′- GAG ATT CTG CCA GGC TCC AC -3′; for 
cg20509869, 5′- GTG GGA CGC TAA CCC TCT TC -3′ and 5′- GGC GGC TGA TTT 
ATC TGG GT -3′; and for GAPDH transcription start site (TSS), 5′- TCT CCC CAC ACA 
CAT GCA CTT -3′ and 5′- CCT AGT CCC AGG GCT TTG ATT -3′’.
Statistics
Data are presented as the mean ± SD of at least three independent experiments. Statistical 
analysis was performed with Student’s t test for comparing two sets of data with assumed 
normal distribution. A p value of less than 0.05 was considered to be significant.
Data availability
Coordinates and structure factors for the DNMT3A–DNMT3L–25-mer DNA, DNMT3A–
DNMT3L–10/11-mer DNA, and DNMT3A (R836A)–DNMT3L–25-mer DNA complexes 
have been deposited in the Protein Data Bank with accession codes 5YX2, 6F57 and 6BRR, 
respectively. The eRRBS and Illumina Human Methylation 450K array data have been 
deposited in NCBI Gene Expression Omnibus (GEO) under accession code GSE99391.
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Code availability
The scripts for genomic data analyses and all other data are available from the corresponding 
authors upon reasonable request.
Extended Data
Extended Data Figure 1. Structures of the DNMT3A–DNMT3L tetramer in complex with the 
10/11-mer DNA
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a, The sequence of the 10/11-mer DNA duplex used for structural study. b, Chemical 
formula of the covalent adduct of DNMT3A and 2′-deoxy-Zebularine. c, Data collection 
and refinement statistics. Each dataset was collected from a single crystal. d, Ribbon 
representations of the DNMT3A–DNMT3L tetramer in complex with the 10/11-mer DNA 
duplex and AdoHcy. DNMT3A, DNMT3L and DNA are colored in light blue, green and 
wheat, respectively, and AdoHcy shown in sphere representation. The boxed areas show 
expanded views for the CpG sites (purple and yellow), the DNA-binding TRD and catalytic 
loops (left box) and the flipped out 2′-deoxy-Zebularine (dZ6′) surrounded by conserved 
catalytic residues (right box). The Fo–Fc omit map of dZ6′ (pink) is contoured at 3σ level. 
The hydrogen-bonding interactions are depicted as dashed lines.
Zhang et al. Page 12
Nature. Author manuscript; available in PMC 2018 August 07.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Extended Data Figure 2. Intermolecular interactions between the DNMT3A–DNMT3L tetramer 
and DNA
a, Structural overlay of free DNMT3A-DNMT3L (PDB 2QRV) with the 10/11-mer DNA 
and 25-mer DNA-bound states. b, Stick representation of the 25-mer DNA duplex bound to 
the DNMT3A-DNMT3L tetramer, with the 2Fo-Fc omit map contoured at 1σ level. c, The 
two helices of DNMT3A that interact with DNMT3L (shown in green) are colored in pink 
(α4 and α5 in accordance with the numeration in Extended Data Figure 3g) and preceded by 
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two DNA contact loops, colored in blue. The flipped out Zebularine (Z5) is colored in 
purple. The bound AdoHcy molecule is shown in sphere representation.
Extended Data Figure 3. Various intermolecular interactions between the two DNMT3A 
monomers and DNA
a–f, DNA binding by the first and second DNMT3A monomer (defined as 3A and 3A′, 
respectively, in Fig. 1c) includes the intermolecular interactions between DNMT3A’s TRD 
loop and DNA major groove (a,d), between DNMT3A’s catalytic loop and DNA minor 
groove (b,e), and between DNMT3A’s homodimeric interface and DNA backbone (c,f). The 
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hydrogen-bonding interactions are shown as dashed lines. The water molecules are shown as 
purple spheres. g, Structure-based sequence alignment of DNMT3 proteins from human 
(hDNMT3A and hDNMT3B), mouse (mDnmt3a and mDnmt3b) and zebrafish (zDnmt3a 
and zDnmt3b). Completely conserved residues are colored in white and highlighted in red. 
Partially conserved residues are colored in red. Secondary structures are shown above the 
aligned sequences. The DNA binding residues as revealed by this study are marked with 
black triangles.
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Extended Data Figure 4. The essential roles for the CpG-engaging residues of DNMT3A, R836 
and V716, in DNMT3A-mediated CpG versus non-CpG methylations
a, b, DNA methylation kinetics analysis of wild-type (DNMT3AWT, panel a) and R836A-
mutated (DNMT3AR836A, panel b) DNMT3A using the CpG-, CpA- or CpT-containing 
DNA substrates (n = 3 biological replicates). Purified DNMT3A–DNMT3L tetramer 
complex was used for measurements, followed by fitting with first-order exponential 
equation. c, Ribbon representation of the crystal structure of DNMT3AR836A–DNMT3L 
tetramer in complex with the 25-mer DNA, with the CpG recognition by one of the 
DNMT3A monomer shown in expanded view. The 2Fo-Fc omit map of DNA was contoured 
at 0.8σ level, and colored in light blue. d, Methylation assay using either DNMT3AWT or 
DNMT3AV716G on CG-, CA- and CT-containing DNA (n = 3 biological replicates). e, 
Immunoblots detect reconstituted expression of the indicated DNMT3A among TKO mouse 
ES cells, either the pooled stable-expression cell population or single cell-derived clonal 
lines. Shown is a representative blot of two independent experiments. For gel source data, 
see Supplementary Figure 1. f, Liquid chromatography–mass spectrometry (LC-MS) 
analysis reveals the global 5-mC levels (as calculated by 5-mdC/dG in y-axis) in the TKO 
ES cells after stable transduction of EV or the indicated DNMT3A (n = 3 biological 
replicates). Data are mean ± s.d. EV, empty vector.
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Extended Data Figure 5. eRRBS reveals distribution of cytosine methylations in each sequence 
context among TKO ES cells with reconstituted expression of either DNMT3AWT or 
DNMT3AR836A
a, The rates of bisulfite conversion for the indicated sequence context in each sample as 
determined by the unmethylated lambda DNA spike-in control. CpN, all cytosines. b, c, 
Piecharts showing the percentage of methylated cytosines (total number n shown at the 
bottom of each plot) identified among the DNMT3AWT or DNMT3AR836A-expressing TKO 
ES cells in each sequence context. The methylated cytosines were called using a stringent 
binomial distribution–based filter to eliminate false positives from incomplete bisulfite 
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conversion, with a false discovery rate (FDR) of 1% and 0.1% set for panel b and c, 
respectively. d, Distribution of methylation levels (% in x-axis) for the indicated sequence 
context. Insert panels show a closed view of the distribution at sites with intermediate to 
high levels of cytosine methylation.
Extended Data Figure 6. CpG and non-CpG methylations induced by DNMT3AWT versus 
DNMT3AR836A in the TKO ES cells
a, Overall methylation levels of cytosines at four different sequence contexts as detected by 
eRRBS. Shown on y-axis is the averaged methylation level of all cytosines within the mouse 
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genome as calculated by normalization of the detected methylation cytosines over total 
cytosine numbers in the TKO ES cells reconstituted with either DNMT3AWT (left) or 
DNMT3AR836A (right). b, Global levels of CpG and CpH (H= A, C or T) methylation 
induced by DNMT3AWT (green) or DNMT3AR836A (red) across the mouse chromosomes of 
the TKO ES cells. Shown are boxplots of 10 kb-bin-averaged methylation levels of each 
mouse chromosome. c, Global levels of CpG and CpH methylation induced by DNMT3AWT 
(green) versus DNMT3AR836 (red) across all annotated genes. Each gene was divided into 
100 equally sized bins and the 10 Kb flanking region was divided into 50 equally sized bins. 
Averaged methylation levels were plotted for each bin. TSS, transcription start site; TES, 
transcription end site. d, Global levels of CpG and CpH methylation induced by 
DNMT3AWT (green) versus DNMT3AR836A (red) on the two opposite DNA strands. Shown 
are boxplots of 10 kb-bin-averaged CpG, CpA, CpC and CpT methylation levels of each 
strand. e, Representative gene-wide views of CpG and CpH methylations at Foxp1 and 
Dock1, which are grouped into either forward (+) or reverse (-) DNA strand. Shown are 
cytosines covered by at least 15 reads from eRRBS data, with each site designated by a 
vertical line. Panels a-e use the combined dataset of three biological replicates per group. 
Box plots depict the interquartile range, and whiskers depict 1.5× interquartile range.
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Extended Data Figure 7. Sanger bisulfite sequencing to validate the cytosine methylation levels 
mediated by DNMT3A, either WT or defective in recognizing the CpG substrate, among the 
TKO mouse ES cells
a, Sequence of the examined major satellite DNA region. Primers used for bisulfite PCR are 
denoted with 5′ and 3′ primer paring. The counts for cytosines, highlighted in color, are 9 
for the CG dinucleotide, 33 for CA, 14 for CT, and 13 for CC. b, A representative result for 
bisulfite sequencing analysis of the major satellite repeat region described above in the TKO 
cells expressing EV, WT DNMT3A or the indicated mutant. Each row represents one DNA 
clone and each column represents one site of cytosine, either methylated (filled) or 
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unmethylated (open). c, d, Percentage of methylation mediated by DNMT3A or the 
indicated mutant at CpG (c) and non-CG (d) sites within the examined major satellite DNA 
region in the TKO ES cells. Data are mean ± s.d.; n= 4 independent bisulfite sequencing 
experiments as shown in b. e-h, Average cytosine methylation levels at each individual site 
grouped by the CpG (e), CpA (f), CpT (g) or CpC (h) context in the examined major 
satellite DNA among the TKO ES cells reconstituted with DNMT3AWT versus 
DNMT3AR836A (n = 4 biological replicates; mean ± s.d., with the labeled p values). EV, 
empty vector. Statistical analysis used two-tailed Student’s t-test: n.s., not significant.
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Extended Data Figure 8. Effect of hematological cancer-associated mutations of DNMT3A on 
DNA methylation in vitro and in mouse TKO ES cells
a, Methylation kinetics of DNMT3A with mutations located at the catalytic loop, in 
comparison to DNMT3AWT. b, Methylation kinetics of DNMT3A with an active site 
mutation, R792H. c, Methylation kinetics of DNMT3A with mutations located at the TRD 
loop. d, Methylation kinetics of DNMT3A with the hotspot mutation R882H. For panels a-
d, DNMT3A–DNMT3L complex was used for the measurements (n = 3 biological 
replicates), followed by fitting with first-order exponential equation. These data were 
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measured independently from data shown in Fig. 4c. e, Immunoblot detects stable 
reconstitution of DNMT3AWT or the indicated DNMT3A mutant in the TKO ES cells. 
Shown is a representative blot of two independent experiments. For gel source data, see 
Supplementary Figure 1. f, LC-MS analysis reveals the global 5-mC levels (as calculated by 
5-mdC/dG) in the TKO ES cells after stable transduction of empty vector (EV) or the 
indicated DNMT3A. Plotted are the methylation levels relative to TKO cells expressing 
DNMT3AWT. Data are mean ± s.d.; n = 4 biological replicates. g, Individual bisulfate 
sequencing detects the methylation level of cytosines in each sequence context within a 
major satellite DNA site at chromosome 2 in the TKO cells reconstituted with 
DNMT3AR836W (right), in comparison to DNMT3AWT (left) or DNMT3AR836A (middle; as 
determined in Fig. 3g) (n = 4; mean ± s.d.). Statistical analysis used two-tailed Student’s t-
test. h, In vitro methylation of CG, CA or CT-containing DNA using DNMT3AWT (left) or 
DNMT3AR836W (right) in complex with DNMT3L, reacted for 40 min (n = 3 biological 
replicates). Plotted are the methylation levels relative to CG-containing DNA substrates. 
Data are mean ± s.d.
Extended Data Figure 9. Effect of hematological cancer-associated mutations of DNMT3A on 
genomic DNA methylation in the TF-1 leukemia cells
a, Immunoblot of the TF-1 cells stably transduced with Myc-tagged DNMT3A, either WT 
or the indicated cancer-associated mutants. EV, empty MSCV vector. Shown is a 
representative blot of two independent experiments. For gel source data, see Supplementary 
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Figure 1. b, Profiling of the indicated DNMT3A-expressing TF-1 cell lines with the 
HumanMethylation_450K BeadChip array reveals the mean methylation beta values for all 
examined CpGs. Each dot represents a biological replicate, i.e., an independently derived 
stable-expression cell line (n = 3-8 biological replicates per group; mean ± s.d.). Statistical 
analysis used two-tailed Student’s t-test. NS, not significant. c, Density plot of methylation 
beta values for all examined CpGs in the indicated DNMT3A-expressing TF-1 cell lines. 
The inserted box shows a zoom-in view for densities for highly methylated DNA sites 
among the indicated samples. Data are mean ± s.d., with the labeled p values. Statistical 
analysis used two-tailed Student’s t-test: NS, not significant. d, Sanger bisulfite sequencing 
of the indicated regions from TF-1 cell lines stably transduced with EV, DNMT3AWT or the 
indicated cancer-associated mutant. Individual CpG sites (circles) are filled with black 
(methylated) or white (unmethylated). Red circles denote the CpG sites covered by the 
Illumina Infinium 450K DNA methylation array. Data are mean ± s.d.; n = 3 biological 
replicates. e, Methylation values of the indicated CpG sites (labeled by red circles in d) 
based on the measurements with the Infinium 450K DNA methylation arrays (n = 3-8 
biological replicates; mean ± s.d.).
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Extended Data Figure 10. Effect of hematological cancer-associated DNMT3A mutations on 
DNA hypo-methylation and cytokine-independent growth of the TF-1 leukemia cells
a, Venn diagram of CpG sites with hypo-methylation induced by either one of the three 
indicated strong DNA-binding-defective mutants of DNMT3A, V716D, K841E and R792H. 
b, c, Bar plots (b) and scatter plots (c) showing methylation difference at the 605 commonly 
hypo-methylated CpG sites identified in panel a among the TF-1 cells with stable 
transduction of either DNMT3AWT or the indicated mutant, in comparison to empty MSCV 
vector (EV). A black line in b indicates EV control (n = 3-8 biological replicates per group; 
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mean ± s.d.). Plotted in c are mean methylation beta values of each individual CpG in the 
indicated DNMT3A experimental group (x-axis) and control EV group (y-axis; n = 3-8 
biological replicates per group). d, e, Comparable occupancy of DNMT3A and its mutant 
forms at the indicated genomic loci with affected DNA methylation, as measured by ChIP 
analysis of the Myc-tagged DNMT3AWT or mutants in TF-1 stable-expression cell lines. 
Tested sites by ChIP-qPCR in panel d (n = 3 biological replicates; mean ± s.d.) included 
three CpG sites showing hypo-methylation due to expression of mutant DNMT3A (left; also 
see Extended Data Fig. 9e), three sites showing hyper-methylation due to expression of 
DNMT3AWT (middle; also see panel e, which shows mean methylation beta values from 
measurements with the Infinium 450K DNA methylation arrays, n = 3-8 biological 
replicates; mean ± s.d.), and a negative control locus (right; the GAPDH transcription start 
site). The anti-Myc antibody was used for ChIP and the EV-expressing TF-1 cells used as 
cell control for unspecific binding. f, Proliferation of the indicated DNMT3A stable-
expression TF-1 cells in the presence of a supporting cytokine, GM-CSF (n = 2 biological 
replicates; mean ± s.d.). g, Proliferation of the indicated DNMT3A-expressing TF-1 cells 
after GM-CSF withdrawal (n = 3 biological replicates; mean ± s.d.).
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Structure of the DNMT3A–DNMT3L tetramer in complex with a 25-mer DNA duplex 
containing two CpG sites
a, Domain architectures of DNMT3A and DNMT3L, with the C-terminal domains marked 
with arrowheads. b, DNA sequence used for structural study. Z, Zebularine. c, d, Ribbon (c) 
and surface (d) representations of DNMT3A–DNMT3L bound to DNA and AdoHcy. The 
Zebularines anchored at the two active sites are 14-bp away and shown in expanded views, 
with hydrogen-bonding interactions depicted as dashed lines and the Fo–Fc omit map (pink) 
of Z5 or Z20′ contoured at 3σ level.
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Figure 2. Structure comparison of free and DNA-bound DNMT3A–DNMT3L tetramer
a, Schematic view of the intermolecular interactions between DNMT3A and DNA. The 
hydrogen-bonding, electrostatic and van der Waals contacts are represented by red, blue and 
black arrows, respectively. Water-mediated hydrogen bonds are labeled with letter ‘W’. b, 
Structural overlay of free (grey) and DNA-bound (cyan) DNMT3A–DNMT3L. The 
disordered TRD loops in free DNMT3A-DNMT3L are depicted as dotted lines. c, The TRD 
loop (blue) in DNA-bound DNMT3A is stabilized by hydrogen-bonding interactions 
(dashed lines) with R882 and Q886. d, Structural overlay of the catalytic loop between free 
(grey) and DNA-bound (blue) DNMT3A. e, DNA intercalation by DNMT3A V716.
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Figure 3. DNMT3A–CpG interactions
a, b, Interactions of R836 (a) and V716-P718 (b) with one CpG site. The hydrogen bonds 
and water molecule are shown as dashed lines and purple sphere, respectively. Nucleotides 
in the second CpG site are shown in parenthesis. c, 40-min in vitro methylation using 
DNMT3AWT–DNMT3L or DNMT3AR836A–DNMT3L complex (n = 3 biological 
replicates). d, Composition of all called methylated cytosines (mC) in TKO ESCs 
reconstituted with DNMT3AWT or DNMT3AR836A. An mC is defined using a binomial 
distribution-based filter with FDR less than 1% (n = 21,678,839 for WT and n = 25,272,362 
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for R836A). e, f, eRRBS revealing averaged CpG and non-CpG methylations, either at 
global levels (e) or at a representative major satellite DNA region (f), that are induced by 
DNMT3AWT versus DNMT3AR836A among 3 independent lines of TKO ESCs. Shown in e 
are boxplots of 10 kb-bin-averaged methylation levels for each sequence context. +/−, 
forward/reverse strand. Box plots and whiskers depict the interquartile and 1.5× interquartile 
ranges, respectively. g, Individual bisulfate sequencing detecting the methylation level of 
CG, CA, CT or CC sites within a major satellite DNA site at chromosome 2 in TKO cells 
expressing DNMT3AWT or DNMT3AR836A (n = 4). Data are mean ± s.d. Statistical analysis 
used two-tailed Student’s t-test. ***, p < 0.001.
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Figure 4. Hematological cancer-associated mutations of the DNMT3A–DNA interaction residues
a, b, Surface (a) and stick (b) views of DNMT3A’s DNA-contacting residues found mutated 
in hematological cancer. Mutation sites are colored blue in a. The hydrogen-bonding 
interactions and water molecule are shown as dashed lines and purple sphere, respectively. c, 
In vitro methylation of CpG DNA using DNMT3AWT or its hematological cancer-associated 
mutants (n = 3). d, DNMT3A immunoblots (top) and LC-MS-based quantification of mC 
(bottom, n = 3 biological replicates) among TKO ESCs re-expressing DNMT3AWT alone 
(##, non-tagged) or together with the equal amount of the indicated DNMT3A mutant (#, 
tagged). Shown is a representative blot of two independent experiments. For gel source data, 
see Supplementary Figure 1. e, Scatter plots showing mean methylation beta values of each 
individual CpG among TF1 cells with stable expression of the indicated DNMT3A mutant 
(y-axis; n = 3-8 biological replicates) in comparison to empty vector controls (EV, x-axis), 
with significantly differentially methylated CpGs depicted in red. f, Proliferation of the 
indicated DNMT3A-expressing TF-1 cells under cytokine-poor conditions (n = 3). Data are 
mean ± s.d. Statistical analysis used two-tailed Student’s t-test. ***, p < 0.001.
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